Drug Combination Details
| General Information of the Combination (ID: C07781) | |||||
|---|---|---|---|---|---|
| Name | Paclitaxel NP Info | + | Gemcitabine Drug Info | ||
| Structure |
|
+ |
|
||
| Disease |
Pancreatic cancer
[ICD-11: 2C10]
|
Phase 4 | [1] | ||
|
Breast cancer
[ICD-11: 2C60]
|
Investigative | [2] | |||
| Combinatorial Therapeutic Effect(s) Validated Clinically or Experimentally | ||||||
|---|---|---|---|---|---|---|
| α. Enhancing Drug Efficacy by This Combination | ||||||
| Achieving Therapeutic Synergy | Click to Show/Hide | |||||
| Experiment 1 Reporting the Effect of This Combination | [2] | |||||
| In-vivo Model | Clinical trial review | |||||
| Experimental
Result(s) |
The combination was very well tolerated and was not associated with any adverse impact in quality of life compared with paclitaxel alone. | |||||
